Production of tumor angiogenesis factor by cell culture
US4210719A · kind A · utility
3Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 1978 |
| Grant date | Jul 1, 1980 |
| Priority date | — |
| Expiry date | Dec 29, 1998 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/948
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Process for the production of human TAF in vitro comprising growing the human rhabdomyosarcoma cell line RD in agitated, liquid suspension of nutrient culture medium at about 35.degree.-38.degree. C. for a sufficient time to elaborate TAF and recovering the resulting TAF from the cells or cell product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.